SK2 Channels as Novel Neuroprotective Targets Against Cerebral Ischemia
SK2 Channels as Novel Neuroprotective Targets Against Cerebral Ischemia
批准号:
7697729
负责人:
JOHN P ADELMAN
金额:
$33.8万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-01 至 2013-05-31
关键词:
Adverse effectsAreaAttenuatedBrainBrain InjuriesBrain IschemiaCalcium-Activated Potassium ChannelCardiopulmonary ResuscitationCause of DeathCell DeathCerebral IschemiaCessation of lifeChemosensitizationClinical TrialsCognitiveCyclic AMP-Dependent Protein KinasesDoseElectrophysiology (science)EndocytosisExcitatory Amino Acid AntagonistsExcitatory Postsynaptic PotentialsFrequenciesGeneticGlutamate ReceptorGlutamatesHeartHeart ArrestHippocampus (Brain)HumanImageImmuneImmunoelectron MicroscopyImpaired cognitionInterventionIschemiaLearningLong-Term EffectsLong-Term PotentiationMeasuresMediatingMemoryMemory impairmentModificationMusMyocardial InfarctionN-MethylaspartateNeurological outcomeNeuronsOutcomePatternPerformancePharmaceutical PreparationsPhosphorylationPhysiologicalPositioning AttributeQuality of lifeResearchRoleSliceStimulusStrokeSynapsesSynaptic plasticityTestingTherapeuticTimeUnited StatesUpdateVertebral columndisabilityexcitotoxicityimprovedin vivomouse modelneuronal survivalneuroprotectionneurotransmissionnovelpostsynapticpreventpublic health relevanceresponsetherapeutic targettransmission processtwo-photon
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Cardiac arrest/cardiopulmonary resuscitation (CA/CPR) causes ischemia, neuronal excitotoxicity and cognitive decline. Despite intensive efforts, outcome remains poor. Excitotoxicity results from increased glutamate neurotransmission, and the consequent excessive Ca2+ influx through NMDA-type glutamate receptors (NMDAr). Hippocampal CA1 neurons are important to learning and memory and are acutely sensitive to excitotoxicity. We have shown that small conductance Ca2+-activated K+ channels, type 2 (SK2 channels) are expressed together with NMDAr in the spines on hippocampal CA1 neurons where they act to attenuate Ca2+ influx through NMDAr. In addition, SK2 channels are removed from synapses following patterned activity, either normally as for the induction of long term potentiation (LTP), or abnormally after CA/CPR. The loss of synaptic SK2 channels removes the SK channel 'brake' on Ca2+ influx through NMDAr and is due to protein kinase A phosphorylation of the SK2 channels. Our results further show that increasing SK2 channel activity substantially improves neuronal survival after CA/CPR. Therefore, we will use an integrated technical repertoire to test these specific hypotheses: 1. Genetic or pharmacologic enhancement of SK2 channel activity protects CA1 neurons and improves cognitive outcome. We will use genetic mouse models and SK enhancing drugs to determine the i) survival of CA1 neurons and, ii) cognitive performance. 2. CA/CPR-induced ischemia causes a delayed and prolonged loss of synaptic SK2 channels in CA1 neurons, increasing the NMDAr-dependent Ca2+ transient that causes excitotoxicity. Preserving synaptic SK2 channel activity after CA/CPR protects CA1 neurons. We will measure the time course and effects of ischemia on the SK2 and NMDAr contributions to glutamate transmission (EPSP), and NMDAr-mediated Ca2+ transients. 3. CA/CPR-induced ischemia causes PKA phosphorylation of spine SK2 channels, inducing channel endocytosis. Expression of PKA-immune SK2 channels will normalize the SK2 and NMDAr contributions to the EPSP, the NMDAr-dependent Ca2+ transient, and protect CA1 neurons from excitotoxic cell death. We will use control mice or mice expressing PKA-immune SK2 channels to determine: i) the sub-spine distribution of SK2 channels; ii) the SK2 and NMDAr contributions to the EPSP; iii) the spine Ca2+ transient; iv) CA1 viability. 4. The aberrantly sustained ischemia-induced loss of synaptic SK2 channels results in ischemic LTP (iLTP) that shifts ?m, the modification threshold, to higher stimulus frequencies and impairs further potentiation. Maintained expression of functional synaptic SK2 channels prevents iLTP and normalizes ?m. We will measure the long-term effects of CA/CPR-induced ischemia on synaptic plasticity. PUBLIC HEALTH RELEVANCE: Heart attack and the consequent cerebral ischemia is one of the leading causes of death and disability in the United States and, unfortunately, there are currently no drugs available that improve outcome following severe heart attack requiring cardio-pulmonary resuscitation. SK2 channels, one type of Ca2+- activated K+ channel, are anatomically and functionally poised to ameliorate brain damage following stroke. The proposed studies will demonstrate the neuroprotective role of SK2 channels and suggest novel interventional strategies to protect the brain following heart attack, improving survival, diminishing memory deficits, and improving quality of life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Site-directed RNA editing: a new method to correct disease causing mutations
-
批准号:8548205
-
项目类别:
-
资助金额:$69.55万
-
财政年份:2013
-
负责人:JOHN P ADELMAN
-
依托单位:
Site-directed RNA editing: a new method to correct disease causing mutations
-
批准号:8900376
-
项目类别:
-
资助金额:$68.2万
-
财政年份:2013
-
负责人:JOHN P ADELMAN
-
依托单位:
Site-directed RNA editing: a new method to correct disease causing mutations
-
批准号:9325591
-
项目类别:
-
资助金额:$68.2万
-
财政年份:2013
-
负责人:JOHN P ADELMAN
-
依托单位:
Site-directed RNA editing: a new method to correct disease causing mutations
-
批准号:9117649
-
项目类别:
-
资助金额:$68.2万
-
财政年份:2013
-
负责人:JOHN P ADELMAN
-
依托单位:
Site-directed RNA editing: a new method to correct disease causing mutations
-
批准号:8738740
-
项目类别:
-
资助金额:$67.52万
-
财政年份:2013
-
负责人:JOHN P ADELMAN
-
依托单位:
Coupled LTP-dependent trafficking of synaptic SK channels and NMDARs
-
批准号:8661293
-
项目类别:
-
资助金额:$30.06万
-
财政年份:2012
-
负责人:JOHN P ADELMAN
-
依托单位:
Coupled LTP-dependent trafficking of synaptic SK channels and NMDARs
-
批准号:8289226
-
项目类别:
-
资助金额:$31.0万
-
财政年份:2012
-
负责人:JOHN P ADELMAN
-
依托单位:
Coupled LTP-dependent trafficking of synaptic SK channels and NMDARs
-
批准号:8471779
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2012
-
负责人:JOHN P ADELMAN
-
依托单位:
Molecular definition of the slow AHP channels in CA1 neurons
-
批准号:8066946
-
项目类别:
-
资助金额:$18.87万
-
财政年份:2010
-
负责人:JOHN P ADELMAN
-
依托单位:
Molecular definition of the slow AHP channels in CA1 neurons
-
批准号:7979132
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2010
-
负责人:JOHN P ADELMAN
-
依托单位:
SK2 Channels as Novel Neuroprotective Targets Against Cerebral Ischemia
-
批准号:8269708
-
项目类别:
-
资助金额:$32.6万
-
财政年份:2009
-
负责人:JOHN P ADELMAN
-
依托单位:
SK2 Channels as Novel Neuroprotective Targets Against Cerebral Ischemia
-
批准号:8074360
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2009
-
负责人:JOHN P ADELMAN
-
依托单位:
2008 Ion Channels Gordon Research Conference
-
批准号:7483370
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2008
-
负责人:JOHN P ADELMAN
-
依托单位:
GABA-A Receptor Rescue as a Neuroprotective Strategy in Cerebral Ischemia
-
批准号:8074896
-
项目类别:
-
资助金额:$41.47万
-
财政年份:2007
-
负责人:JOHN P ADELMAN
-
依托单位:
SK2-associated protein kinase CK2: molecular basis and physiological roles
-
批准号:7249407
-
项目类别:
-
资助金额:$26.84万
-
财政年份:2006
-
负责人:JOHN P ADELMAN
-
依托单位:
SK2-associated protein kinase CK2: molecular basis
-
批准号:7014250
-
项目类别:
-
资助金额:$29.0万
-
财政年份:2006
-
负责人:JOHN P ADELMAN
-
依托单位:
SK2-associated protein kinase CK2: molecular basis and physiological roles
-
批准号:7469507
-
项目类别:
-
资助金额:$26.69万
-
财政年份:2006
-
负责人:JOHN P ADELMAN
-
依托单位:
SK2-associated protein kinase CK2: molecular basis and physiological roles
-
批准号:7661508
-
项目类别:
-
资助金额:$26.54万
-
财政年份:2006
-
负责人:JOHN P ADELMAN
-
依托单位:
SK2-associated protein kinase CK2: molecular basis and physiological roles
-
批准号:7900844
-
项目类别:
-
资助金额:$26.38万
-
财政年份:2006
-
负责人:JOHN P ADELMAN
-
依托单位:
Cloning of the slow AHP channel
-
批准号:6950195
-
项目类别:
-
资助金额:$16.02万
-
财政年份:2005
-
负责人:JOHN P ADELMAN
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: